Jump to content
 







Main menu
   


Navigation  



Main page
Contents
Current events
Random article
About Wikipedia
Contact us
Donate
 




Contribute  



Help
Learn to edit
Community portal
Recent changes
Upload file
 








Search  

































Create account

Log in
 









Create account
 Log in
 




Pages for logged out editors learn more  



Contributions
Talk
 



















Contents

   



(Top)
 


1 References  





2 External links  














Diflorasone diacetate






Português
Tiếng Vit
 

Edit links
 









Article
Talk
 

















Read
Edit
View history
 








Tools
   


Actions  



Read
Edit
View history
 




General  



What links here
Related changes
Upload file
Special pages
Permanent link
Page information
Cite this page
Get shortened URL
Download QR code
Wikidata item
 




Print/export  



Download as PDF
Printable version
 
















Appearance
   

 






From Wikipedia, the free encyclopedia
 


Diflorasone diacetate
Clinical data
Trade namesPsorcon
AHFS/Drugs.comMonograph
MedlinePlusa602019
License data
Routes of
administration
Topical
ATC code
Legal status
Legal status
Identifiers
  • [17-(2-Acetyloxyacetyl)- 6,9-difluoro-11-hydroxy-10,13,16-trimethyl-3-oxo-6,7,8,11,12,14,15,16- octahydrocyclopenta[a]phenanthren-17-yl] acetate

CAS Number
PubChem CID
IUPHAR/BPS
DrugBank
ChemSpider
UNII
KEGG
ChEBI
ChEMBL
CompTox Dashboard (EPA)
ECHA InfoCard100.046.872 Edit this at Wikidata
Chemical and physical data
FormulaC26H32F2O7
Molar mass494.532 g·mol−1
  • InChI=1S/C26H32F2O7/c1-13-8-17-18-10-20(27)19-9-16(31)6-7-23(19,4)25(18,28)21(32)11-24(17,5)26(13,35-15(3)30)22(33)12-34-14(2)29/h6-7,9,13,17-18,20-21,32H,8,10-12H2,1-5H3/t13-,17-,18-,20-,21-,23-,24-,25-,26-/m0/s1 checkY

  • Key:BOBLHFUVNSFZPJ-JOYXJVLSSA-N checkY

 ☒NcheckY (what is this?)  (verify)

Diflorasone diacetate is a topical steroid that comes in the form of a cream. It is manufactured by E. Fougera & Co. and is used as an anti-inflammatory and anti-itching agent, like other topical corticosteroids. It is prescribed for psoriasis[1] and atopic dermatitis, among other conditions. With respect to potency, it is regarded as a Class I corticosteroid [of classes I – VII] in the United States.[2]

No long-term animal studies have been done to determine whether diflorasone diacetate could have carcinogenic properties.[citation needed]

Little data is available regarding whether diflorasone diacetate would be present in great enough quantities to cause harm to an infant.[3]

References[edit]

  1. ^ Shupack JL, Jondreau L, Kenny C, Stiller MJ (1993). "Diflorasone diacetate ointment 0.05% versus betamethasone dipropionate ointment 0.05% in moderate-severe plaque-type psoriasis". Dermatology. 186 (2): 129–32. doi:10.1159/000247323. PMID 8428041.
  • ^ "Topical Steroids Potency Chart". psoriasis.org.
  • ^ "Diflorasone topical". Drugs.com.
  • External links[edit]


  • t
  • e

  • Retrieved from "https://en.wikipedia.org/w/index.php?title=Diflorasone_diacetate&oldid=1095684590"

    Categories: 
    Corticosteroid esters
    Corticosteroids
    Organofluorides
    Acetate esters
    Dermatologic drug stubs
    Hidden categories: 
    Articles with short description
    Short description matches Wikidata
    Articles with changed CASNo identifier
    Articles with changed EBI identifier
    ECHA InfoCard ID from Wikidata
    Drugboxes which contain changes to verified fields
    All articles with unsourced statements
    Articles with unsourced statements from April 2015
    All stub articles
     



    This page was last edited on 29 June 2022, at 18:51 (UTC).

    Text is available under the Creative Commons Attribution-ShareAlike License 4.0; additional terms may apply. By using this site, you agree to the Terms of Use and Privacy Policy. Wikipedia® is a registered trademark of the Wikimedia Foundation, Inc., a non-profit organization.



    Privacy policy

    About Wikipedia

    Disclaimers

    Contact Wikipedia

    Code of Conduct

    Developers

    Statistics

    Cookie statement

    Mobile view



    Wikimedia Foundation
    Powered by MediaWiki